Electromed (ELMD) director reports 3,000-share restricted stock grant on Form 4

Rhea-AI Filing Summary

Electromed, Inc. reported a Form 4 insider transaction for a company director. On 12/01/2025, the director acquired 3,000 shares of common stock, coded as an "A" transaction, at a reported price of $0, indicating a grant rather than an open-market purchase. These shares are described as restricted stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated under their terms.

Following this grant, the director beneficially owned 21,000 shares of Electromed common stock in direct form. The filing is made by a single reporting person in the capacity of Director of Electromed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fluet Gregory

(Last) (First) (Middle)

500 SIXTH AVENUE NW

(Street)

NEW PRAGUE MN 56071

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Electromed, Inc. [ ELMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/01/2025		A		3,000(1)	A	$0	21,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

	/s/ Joshua L. Colburn, Attorney-in-fact	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Electromed (ELMD) report in this Form 4?

Electromed reported that a company director acquired 3,000 shares of common stock on 12/01/2025, shown as an "A" (acquired) transaction at a reported price of $0.

What type of shares did the Electromed (ELMD) director receive?

The shares are described as restricted stock, scheduled to vest on June 1, 2026, unless earlier accelerated or terminated under their terms.

How many Electromed (ELMD) shares does the director own after this transaction?

After the reported transaction, the director beneficially owned 21,000 shares of Electromed common stock, held as direct ownership.

What is the director’s relationship to Electromed (ELMD) in this filing?

The reporting person is identified as a Director of Electromed, Inc., with the Form 4 indicating it was filed by one reporting person.

Was this Electromed (ELMD) Form 4 filed jointly with other insiders?

No. The form indicates it is filed by one reporting person, not by more than one reporting person.

Does this Electromed (ELMD) Form 4 involve any derivative securities?

No derivative securities are listed in Table II; the reported activity involves non-derivative common stock only.